Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 245,756Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 9Mirum Pharmaceuticals

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

MARALIXIBAT CHLORIDE

Brand Name : LIVMARLI

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 9.5MG BASE/ML

Packaging :

Approval Date : 2021-09-29

Application Number : 214662

Regulatory Info : RX

Registration Country : USA

blank

02

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

MARALIXIBAT CHLORIDE

Brand Name : LIVMARLI

Dosage Form : SOLUTION;ORAL

Dosage Strength : EQ 19MG BASE/ML

Packaging :

Approval Date : 2024-07-24

Application Number : 214662

Regulatory Info : RX

Registration Country : USA

blank

03

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

MARALIXIBAT CHLORIDE

Brand Name : LIVMARLI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 10MG BASE

Packaging :

Approval Date : 2025-04-10

Application Number : 219485

Regulatory Info : RX

Registration Country : USA

blank

04

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

MARALIXIBAT CHLORIDE

Brand Name : LIVMARLI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 15MG BASE

Packaging :

Approval Date : 2025-04-10

Application Number : 219485

Regulatory Info : RX

Registration Country : USA

blank

05

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

MARALIXIBAT CHLORIDE

Brand Name : LIVMARLI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 20MG BASE

Packaging :

Approval Date : 2025-04-10

Application Number : 219485

Regulatory Info : RX

Registration Country : USA

blank

06

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

MARALIXIBAT CHLORIDE

Brand Name : LIVMARLI

Dosage Form : TABLET;ORAL

Dosage Strength : EQ 30MG BASE

Packaging :

Approval Date : 2025-04-10

Application Number : 219485

Regulatory Info : RX

Registration Country : USA

blank

07

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Maralixibatklorid

Brand Name : Livmarli

Dosage Form : Oral Solution

Dosage Strength : 9.5mg/ml

Packaging :

Approval Date : 12/12/2022

Application Number : 20210927000029

Regulatory Info : Approved

Registration Country : Sweden

blank

08

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Maralixibatum

Brand Name : Livmarli

Dosage Form : Oral Solution

Dosage Strength : 9.5mg/ml

Packaging :

Approval Date : 18/07/2024

Application Number : 69201

Regulatory Info : Allowed

Registration Country : Switzerland

blank

09

Aus. Peptide Conference
Not Confirmed
arrow
arrow
Aus. Peptide Conference
Not Confirmed

Maralixibat Chloride

Brand Name : Livmarli

Dosage Form : Oral Solution

Dosage Strength : 9.5MG

Packaging :

Approval Date : 2023-03-24

Application Number : 1221704001

Regulatory Info : Authorized

Registration Country : Spain

blank